Drug Coverage and Access
In recent years, patients are living longer thanks to the discovery and approval of newer treatments. Historically, treatment options for myeloma patients were limited to traditional chemotherapy, radiation, and/or high-dose chemotherapy, also known as an autologous stem cell transplant. Over the past 15 years, treatment options have increased significantly with the addition of novel, targeted agents. Click on the links below to learn more about the drug approval and reimbursement process in Canada, as well as how we advocate for the myeloma patient community.